Genome-wide methylation analyses showed that the glioma CpG island methylator phenotype (G-CIMP), which is named after the well-known CIMP status observed in colorectal cancers, is frequent in lower-grade gliomas and secondary GBMs and is tightly associated with the presence of IDH mutations8,9. This evidence concerns the gene IDH1 and central nervous system cancer.